Livagen

Chromatin studies

Hepatic models

Consistent with its assignment to liver tissue, KEDA has been examined in hepatocyte cultures and in rodent liver preparations, with endpoints including viability, protein synthesis markers, histology, and transcript levels for a small gene panel. Reported outcomes are modest and vary with the model and the challenge applied.

Position in the series

KEDA is the KED tripeptide of Vesugen extended by an alanine. Because alanine adds only a methyl side chain, the pair is a clean test of whether a minimal, uncharged extension shifts behaviour — a comparison that recurs throughout the structure-activity discussions of this peptide family.

Proposed mechanism

The explanation put forward by the originating groups is that peptides this small pass through membranes without a transporter, reach the nucleus, and bind specific sequences in the major groove of DNA or interact with histones, altering which genes are accessible. Supporting evidence is largely spectroscopic and cytological, and no complete mechanistic account has been established.

Working with the compound

Because much of the Livagen literature involves primary lymphocyte culture, donor-to-donor variability is a real factor in reproducing published results. Reporting donor age, culture conditions, and scoring criteria in detail makes such experiments far easier to compare across laboratories.

Keep the sealed vial at −20 °C, protected from light and moisture, and allow it to warm to room temperature before opening so that condensation does not settle on the lyophilized cake. Reconstitute with bacteriostatic or sterile water run slowly down the inside wall, then swirl gently until clear; avoid shaking or vortexing. Store the resulting solution at 2–8 °C in the dark and label it with the concentration and date. For cell-culture work, filter-sterilise into a suitable buffer and prepare single-use aliquots to limit freeze-thaw cycles.